Home / Expertise / Competition & EU
five swimmers jumping together into water

Competition & EU


The CMS Competition & EU group has more than 225 competition lawyers in 48 cities in 35 countries, making it one of the largest competition teams in Europe. Our widespread local presence - complemented by the CMS EU Law Office in Brussels is virtually unparalleled in Europe.

Competition and regulatory authorities now possess far-reaching powers to investigate companies and commercial arrangements, prohibit M&A deals, force divestment of merged businesses, review markets and impose penalties. There is the additional risk of private enforcement such as substantial (follow-on) antitrust damages claims. It is critical to remain compliant and implement effective risk mitigation strategies

We aim to solve problems and, where possible, to help you avoid them in the first place.

Our large team of competition lawyers has extensive experience in helping navigate these difficult paths – so you can focus on your business. We have in-depth knowledge of competition rules across different countries and markets.

Competition & EU group

  • This group has more than 225 competition lawyers in 48 cities across 35 countries, making it one of the largest competition teams in Europe. Our widespread local presence - complemented by the CMS EU Law Office in Brussels – is virtually unparalleled in Europe.

Working across borders

  • We combine formidable cross-border capacity with a deep understanding of how competition rules apply in practice in different markets
  • Our wide, hands-on experience of dealing with both the European Commission and the EU's national competition authorities and sector regulators, as well as European and national courts, helps us find optimal strategies for our clients. And with a growing presence in China, Latin America and Africa, we offer global solutions to your competition law challenges
  • Our global approach is reflected in a broad offering and highly successful track record. In addition to our local advice, we often coordinate work involving other jurisdictions outside Europe.

Delivering commercial solutions

  • As well as being experts in the theory and practice of competition law, we understand what it means to your industry and your business. CMS is built around sector specialisms, enabling us to understand your commercial and regulatory environment and deliver practical real-world solutions. Our lawyers are frequently praised for their pragmatic, business-oriented approach – getting to grips with the issues that matter most to our clients.

Covering every angle

We act for clients in all areas of competition law:

  • Distribution agreements and arrangements with potential horizontal and vertical restraints
  • Abuse of dominance
  • Merger control (particularly involving complex, multi-jurisdictional filings)
  • Private enforcement
  • State aid
  • Investigations and compliance.

We are among the market leaders in damage claims proceedings, representing claimants as well as defendants. And, of course, we regularly advise on day-to-day competition issues, including commercial agreements and compliance programmes, as well as providing competition law training and audits for clients.

The group has recently launched the CMS Dawn Raid App, letting clients benefit from real-time dawn raid assistance via their smartphone in 27 countries where CMS operates.

Please reach out to any of our Competition & EU lawyers should you have an issue to explore.

See our most recent CMS Expert Guides on Competition Law and State Aid Law in Europe in the Covid-19 crisis. For the very latest legal updates from CMS expert lawyers delivered directly to your inbox, sign up to the Law-Now subscription service now.  

Read more Read less
27 March 2020
CMS Ex­pert Guide to an­ti­trust law and le­gis­la­tion dur­ing Cov­id-19
 Any busi­ness in the world could be af­fected by the coronavir­us (COV­ID-19) pan­dem­ic. For many, ur­gent meas­ures need to be taken to avoid ser­i­ous fin­an­cial con­sequences as a res­ult of these chal­len­ging and un­pre­ced­en­ted times.Busi­ness mod­els will like
08 April 2020
CMS Ex­pert Guide to state aid in the EU dur­ing coronavir­us crisis
 The Coronavir­us (COV­ID-19) pan­dem­ic is hav­ing a sig­ni­fic­ant eco­nom­ic im­pact around the world. In re­sponse to this, EU Mem­ber States have es­tab­lished (or are plan­ning fur­ther) sup­port meas­ures for busi­nesses. Some of these sup­port meas­ures may amount
CMS Dawn Raid App


Show only
11 May 2021
The Bel­gian Com­pet­i­tion Au­thor­ity im­poses a EUR 859,310 fine on Caud­alie...
On 6 May 2021, the Bel­gian Com­pet­i­tion Au­thor­ity im­posed a fine of EUR 859,310 on sev­er­al com­pan­ies of the French Caud­alie group for breach­ing com­pet­i­tion law by im­pos­ing min­im­um prices and re­strict­ing...
10 May 2021
The Court of Justice of the EU cla­ri­fies the dur­a­tion of an in­fringe­ment...
In its pre­lim­in­ary rul­ing of 14 Janu­ary 2021, the Court of Justice of the EU cla­ri­fied the dur­a­tion of an in­fringe­ment in the event of col­lu­sion in a pub­lic tender. De­term­in­ing the end date of the in­fringe­ment...
10 May 2021
Vi­ol­a­tion of mer­ger con­trol pro­ced­ur­al rules: European Com­mis­sion fines...
On 3 May 2021, the European Com­mis­sion fined chem­ic­al maker Sigma-Ald­rich EUR 7.5 mil­lion for provid­ing mis­lead­ing in­form­a­tion dur­ing mer­ger con­trol pro­ceed­ings for Sigma-Ald­rich’s takeover by rival...
07 May 2021
New com­pet­i­tion le­gis­la­tion in Croa­tia – key takeaways
In terms of com­pet­i­tion law in Croa­tia, the past few months have been lively. In April 2021, the Croa­tian Par­lia­ment ad­op­ted an amend­ment to the Croa­tian Com­pet­i­tion Act (the “Amend­ment”). The main...
07 May 2021
Ger­man par­lia­ment ad­opts law to im­ple­ment UTP Dir­ect­ive
On 6 May, the Ger­man par­lia­ment form­ally ap­proved the trans­pos­i­tion law for the UTP-Dir­ect­ive. Sched­uled for ap­prov­al by the Fed­er­al Coun­cil at end of May, the law will in­tro­duce a high­er level of pro­tec­tion...
06 May 2021
High­lights on New Reg­u­la­tions on Su­per­vi­sion and Ad­min­is­tra­tion of Med­ic­al...
On 18 March 2021, the State Coun­cil pro­mul­gated the Reg­u­la­tions on Su­per­vi­sion and Ad­min­is­tra­tion of Med­ic­al Devices (Re­vised in 2021), which will take ef­fect on 1 June 2021 (the "New Med­ic­al Device Reg­u­la­tions")...
05 May 2021
Com­pet­i­tion law en­force­ment in the phar­ma­ceut­ic­als sec­tor in Ukraine
1. Is there any spe­cif­ic reg­u­lat­ory frame­work that deals with com­pet­i­tion reg­u­la­tion in the phar­ma­ceut­ic­al sec­tor in your coun­try? The phar­ma­ceut­ic­al sec­tor is covered by gen­er­al com­pet­i­tion reg­u­la­tions...
05 May 2021
EU Com­mis­sion pro­poses new in­vest­ig­at­ive re­view tools to tackle mar­ket...
On 5 May 2021, the European Com­mis­sion pro­posed the Reg­u­la­tion of the European Par­lia­ment and of the Coun­cil on for­eign sub­sidies dis­tort­ing the in­tern­al mar­ket (For­eign Sub­sidies Reg­u­la­tion or FSR) to...
05 May 2021
COV­ID-19: The Gen­er­al Court of the EU dis­misses Ry­anair's ap­peals against...
On 14 April 2021, the Gen­er­al Court of the EU, seized by sev­er­al an­nul­ment ac­tions brought by Ry­anair, con­sidered that the guar­an­tees giv­en by Fin­land to Fin­nair (Case T-388/20) and the guar­an­tees giv­en...
04 May 2021
Hun­gary ex­tends scope and dead­line for ap­plic­a­tion of tem­por­ary FDI con­trol...
Un­der FDI Act 2020, Min­istry of In­nov­a­tion and Tech­no­logy ap­prov­al is re­quired for clos­ing a trans­ac­tion if the fol­low­ing con­di­tions are met: The trans­ac­tion in­volves the ac­quis­i­tion of a stra­tegic...
04 May 2021
With Il­lu­mina ac­tion, court to test EU Com­mis­sion's new mer­ger re­fer­ral...
On 29 April 2021, the US life sci­ences com­pany Il­lu­mina con­firmed that it filed an ac­tion be­fore the EU courts ask­ing for an an­nul­ment of the European Com­mis­sion’s de­cision of 19 April 2021 to ac­cept...
30 April 2021
Czech au­thor­it­ies to screen fu­ture for­eign in­vest­ments from 1 May
With ef­fect from 1 May 2021, a new law will en­able the Czech au­thor­it­ies to screen fu­ture for­eign dir­ect in­vest­ments in the Czech Re­pub­lic (FDIs). For­eign in­vestors will now have to con­sider the im­plic­a­tions...